Selected research
Industry Research
Tissue and Organ Transplantation Industry Research Report 2026
Market perspective
The global Tissue and Organ Transplantation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Tissue and Organ Transplantation market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Tissue and Organ Transplantation market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Tissue and Organ Transplantation market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Tissue and Organ Transplantation include Arthrex, Biolife Solutions, Discovery Life Sciences, Medtronic, Stryker Corporation, Teva Pharmaceuticals, Veloxis Pharmaceutical, Zimmer Biomet and Abbvie and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Tissue and Organ Transplantation market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Tissue and Organ Transplantation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tissue and Organ Transplantation Market by Company
Arthrex
Biolife Solutions
Discovery Life Sciences
Medtronic
Stryker Corporation
Teva Pharmaceuticals
Veloxis Pharmaceutical
Zimmer Biomet
Abbvie
Novartis
Tissue and Organ Transplantation Segment by Type
Preservation Solution
Immunosuppressive Drugs
Tissue Products
Tissue and Organ Transplantation Segment by Application
Hospital
Transplant Centers
Others
Tissue and Organ Transplantation Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue and Organ Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue and Organ Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue and Organ Transplantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tissue and Organ Transplantation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Preservation Solution
- Immunosuppressive Drugs
- Tissue Products
Applications
- Hospital
- Transplant Centers
- Others
Companies covered
- Arthrex
- Biolife Solutions
- Discovery Life Sciences
- Medtronic
- Stryker Corporation
- Teva Pharmaceuticals
- Veloxis Pharmaceutical
- Zimmer Biomet
- Abbvie
- Novartis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Tissue and Organ Transplantation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Preservation Solution
- 2.2.3 Immunosuppressive Drugs
- 2.2.4 Tissue Products
- 2.3 Tissue and Organ Transplantation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Transplant Centers
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Tissue and Organ Transplantation Breakdown Data by Type
- 3.1 Global Tissue and Organ Transplantation Historic Market Size by Type (2021-2026)
- 3.2 Global Tissue and Organ Transplantation Forecasted Market Size by Type (2027-2032)
4 Tissue and Organ Transplantation Breakdown Data by Application
- 4.1 Global Tissue and Organ Transplantation Historic Market Size by Application (2021-2026)
- 4.2 Global Tissue and Organ Transplantation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Tissue and Organ Transplantation Market Perspective (2021-2032)
- 5.2 Global Tissue and Organ Transplantation Growth Trends by Region
- 5.2.1 Global Tissue and Organ Transplantation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Tissue and Organ Transplantation Historic Market Size by Region (2021-2026)
- 5.2.3 Tissue and Organ Transplantation Forecasted Market Size by Region (2027-2032)
- 5.3 Tissue and Organ Transplantation Market Dynamics
- 5.3.1 Tissue and Organ Transplantation Industry Trends
- 5.3.2 Tissue and Organ Transplantation Market Drivers
- 5.3.3 Tissue and Organ Transplantation Market Challenges
- 5.3.4 Tissue and Organ Transplantation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Tissue and Organ Transplantation Players by Revenue
- 6.1.1 Global Top Tissue and Organ Transplantation Players by Revenue (2021-2026)
- 6.1.2 Global Tissue and Organ Transplantation Revenue Market Share by Players (2021-2026)
- 6.2 Global Tissue and Organ Transplantation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Tissue and Organ Transplantation Head Office and Area Served
- 6.4 Global Tissue and Organ Transplantation Players, Product Type & Application
- 6.5 Global Tissue and Organ Transplantation Manufacturers Established Date
- 6.6 Global Tissue and Organ Transplantation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Tissue and Organ Transplantation Market Size (2021-2032)
- 7.2 North America Tissue and Organ Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 7.4 North America Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Tissue and Organ Transplantation Market Size (2021-2032)
- 8.2 Europe Tissue and Organ Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 8.4 Europe Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Tissue and Organ Transplantation Market Size (2021-2032)
- 9.2 Asia-Pacific Tissue and Organ Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Tissue and Organ Transplantation Market Size (2021-2032)
- 10.2 South America Tissue and Organ Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 10.4 South America Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Tissue and Organ Transplantation Market Size (2021-2032)
- 11.2 Middle East & Africa Tissue and Organ Transplantation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Tissue and Organ Transplantation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Tissue and Organ Transplantation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Arthrex
- 12.1.1 Arthrex Company Information
- 12.1.2 Arthrex Business Overview
- 12.1.3 Arthrex Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.1.4 Arthrex Tissue and Organ Transplantation Product Portfolio
- 12.1.5 Arthrex Recent Developments
- 12.2 Biolife Solutions
- 12.2.1 Biolife Solutions Company Information
- 12.2.2 Biolife Solutions Business Overview
- 12.2.3 Biolife Solutions Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.2.4 Biolife Solutions Tissue and Organ Transplantation Product Portfolio
- 12.2.5 Biolife Solutions Recent Developments
- 12.3 Discovery Life Sciences
- 12.3.1 Discovery Life Sciences Company Information
- 12.3.2 Discovery Life Sciences Business Overview
- 12.3.3 Discovery Life Sciences Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.3.4 Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio
- 12.3.5 Discovery Life Sciences Recent Developments
- 12.4 Medtronic
- 12.4.1 Medtronic Company Information
- 12.4.2 Medtronic Business Overview
- 12.4.3 Medtronic Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.4.4 Medtronic Tissue and Organ Transplantation Product Portfolio
- 12.4.5 Medtronic Recent Developments
- 12.5 Stryker Corporation
- 12.5.1 Stryker Corporation Company Information
- 12.5.2 Stryker Corporation Business Overview
- 12.5.3 Stryker Corporation Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.5.4 Stryker Corporation Tissue and Organ Transplantation Product Portfolio
- 12.5.5 Stryker Corporation Recent Developments
- 12.6 Teva Pharmaceuticals
- 12.6.1 Teva Pharmaceuticals Company Information
- 12.6.2 Teva Pharmaceuticals Business Overview
- 12.6.3 Teva Pharmaceuticals Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.6.4 Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio
- 12.6.5 Teva Pharmaceuticals Recent Developments
- 12.7 Veloxis Pharmaceutical
- 12.7.1 Veloxis Pharmaceutical Company Information
- 12.7.2 Veloxis Pharmaceutical Business Overview
- 12.7.3 Veloxis Pharmaceutical Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.7.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio
- 12.7.5 Veloxis Pharmaceutical Recent Developments
- 12.8 Zimmer Biomet
- 12.8.1 Zimmer Biomet Company Information
- 12.8.2 Zimmer Biomet Business Overview
- 12.8.3 Zimmer Biomet Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.8.4 Zimmer Biomet Tissue and Organ Transplantation Product Portfolio
- 12.8.5 Zimmer Biomet Recent Developments
- 12.9 Abbvie
- 12.9.1 Abbvie Company Information
- 12.9.2 Abbvie Business Overview
- 12.9.3 Abbvie Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.9.4 Abbvie Tissue and Organ Transplantation Product Portfolio
- 12.9.5 Abbvie Recent Developments
- 12.10 Novartis
- 12.10.1 Novartis Company Information
- 12.10.2 Novartis Business Overview
- 12.10.3 Novartis Revenue in Tissue and Organ Transplantation Business (2021-2026)
- 12.10.4 Novartis Tissue and Organ Transplantation Product Portfolio
- 12.10.5 Novartis Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst